Pharmacological therapy of bleeding, chronic radiation proctitis
MiFlaPro - multicentre phase III AMG study of chronic haemorrhagic radiation proctitis. The MiFlaPro study is a national, multicentre, double-blind randomised placebo-controlled study on the therapy of bleeding chronic radiation proctitis.
- >> For patients (PDF download - in German)
- >> For medical personnal (PDF download - in German)
- >> For participating centre (Login required)